Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Sheth

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2020
Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implicationsAditi Bhatt, Naoual Bakrin, Witold Gertych, et al.
Plos One|May 4, 2017
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrolRaheem F H Al Aameri, Sandeep Sheth, Entkhab M A Alanisi, et al.
Scientific Reports|July 4, 2019
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing LossSandeep Sheth, Kelly Sheehan, Asmita Dhukhwa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 8, 2016
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the CochleaTejbeer Kaur, Vikrant Borse, Sandeep Sheth, et al.
Expert Opinion on Investigational Drugs|September 23, 2014
Early investigational drugs for hearing lossDebashree Mukherjea, Sumana Ghosh, Puspanjali Bhatta, et al.
Scientific Reports|March 13, 2019
Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the CochleaPuspanjali Bhatta, Asmita Dhukhwa, Kelly Sheehan, et al.
Frontiers in Immunology|April 17, 2023
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicityRaheem F H Al Aameri, Entkhab M A Alanisi, Adu Oluwatosin, et al.
Cell Death & Disease|July 14, 2017
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicityVikrant Borse, Raheem F H Al Aameri, Kelly Sheehan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 1, 2020
Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implicationsAditi Bhatt, Naoual Bakrin, Witold Gertych, et al.
Plos One|May 4, 2017
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrolRaheem F H Al Aameri, Sandeep Sheth, Entkhab M A Alanisi, et al.
Scientific Reports|July 4, 2019
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing LossSandeep Sheth, Kelly Sheehan, Asmita Dhukhwa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 8, 2016
Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the CochleaTejbeer Kaur, Vikrant Borse, Sandeep Sheth, et al.
Expert Opinion on Investigational Drugs|September 23, 2014
Early investigational drugs for hearing lossDebashree Mukherjea, Sumana Ghosh, Puspanjali Bhatta, et al.
Scientific Reports|March 13, 2019
Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the CochleaPuspanjali Bhatta, Asmita Dhukhwa, Kelly Sheehan, et al.
Frontiers in Immunology|April 17, 2023
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicityRaheem F H Al Aameri, Entkhab M A Alanisi, Adu Oluwatosin, et al.
Cell Death & Disease|July 14, 2017
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicityVikrant Borse, Raheem F H Al Aameri, Kelly Sheehan, et al.
Pageof 3